3 min listen
Specialty Drugs Accounted For Most New Product Launches in the Past Decade—Why Do We Know So Little About How Clinical Studies Influence Their Diffusi…
FromThe JM Buzz
Specialty Drugs Accounted For Most New Product Launches in the Past Decade—Why Do We Know So Little About How Clinical Studies Influence Their Diffusi…
FromThe JM Buzz
ratings:
Length:
4 minutes
Released:
Aug 31, 2023
Format:
Podcast episode
Description
What's a more powerful force in driving the diffusion of specialty drugs: marketing or scientific evidence? A new Journal of Marketing study explores.
Read an in-depth recap of this research here: https://www.ama.org/2023/06/13/specialty-drugs-accounted-for-most-new-product-launches-in-the-past-decade-why-do-we-know-so-little-about-how-clinical-studies-influence-their-diffusion/
Read the full Journal of Marketing article here: https://doi.org/10.1177/00222429231177627
Reference: Demetrios Vakratsas and Wei-Lin Wang, “Scientific Evidence Production and Specialty Drug Diffusion,” Journal of Marketing.
Narrator: Elizabeth Ann Sismour
Acknowledgments: Aman Soni
Topics: scientific evidence, specialty drugs, clinical trials, pharmaceutical industry, pharma, healthcare
Read an in-depth recap of this research here: https://www.ama.org/2023/06/13/specialty-drugs-accounted-for-most-new-product-launches-in-the-past-decade-why-do-we-know-so-little-about-how-clinical-studies-influence-their-diffusion/
Read the full Journal of Marketing article here: https://doi.org/10.1177/00222429231177627
Reference: Demetrios Vakratsas and Wei-Lin Wang, “Scientific Evidence Production and Specialty Drug Diffusion,” Journal of Marketing.
Narrator: Elizabeth Ann Sismour
Acknowledgments: Aman Soni
Topics: scientific evidence, specialty drugs, clinical trials, pharmaceutical industry, pharma, healthcare
Released:
Aug 31, 2023
Format:
Podcast episode
Titles in the series (67)
How More Female Executives in the C-Suite Can Spur Improved Customer Orientation and Financial Performance by The JM Buzz